全文获取类型
收费全文 | 172237篇 |
免费 | 33059篇 |
国内免费 | 2534篇 |
专业分类
耳鼻咽喉 | 5357篇 |
儿科学 | 5844篇 |
妇产科学 | 2832篇 |
基础医学 | 6516篇 |
口腔科学 | 1716篇 |
临床医学 | 28752篇 |
内科学 | 52735篇 |
皮肤病学 | 7750篇 |
神经病学 | 16634篇 |
特种医学 | 7330篇 |
外国民族医学 | 8篇 |
外科学 | 44659篇 |
综合类 | 296篇 |
现状与发展 | 72篇 |
一般理论 | 4篇 |
预防医学 | 8240篇 |
眼科学 | 3520篇 |
药学 | 2185篇 |
中国医学 | 47篇 |
肿瘤学 | 13333篇 |
出版年
2024年 | 693篇 |
2023年 | 4886篇 |
2022年 | 1380篇 |
2021年 | 3619篇 |
2020年 | 6328篇 |
2019年 | 2694篇 |
2018年 | 7967篇 |
2017年 | 7713篇 |
2016年 | 8873篇 |
2015年 | 9011篇 |
2014年 | 16295篇 |
2013年 | 16671篇 |
2012年 | 7209篇 |
2011年 | 7190篇 |
2010年 | 11319篇 |
2009年 | 15173篇 |
2008年 | 7309篇 |
2007年 | 5562篇 |
2006年 | 7991篇 |
2005年 | 5329篇 |
2004年 | 4474篇 |
2003年 | 3368篇 |
2002年 | 3368篇 |
2001年 | 3958篇 |
2000年 | 3125篇 |
1999年 | 3390篇 |
1998年 | 3867篇 |
1997年 | 3660篇 |
1996年 | 3523篇 |
1995年 | 3344篇 |
1994年 | 2042篇 |
1993年 | 1687篇 |
1992年 | 1465篇 |
1991年 | 1471篇 |
1990年 | 1121篇 |
1989年 | 1215篇 |
1988年 | 1059篇 |
1987年 | 883篇 |
1986年 | 924篇 |
1985年 | 754篇 |
1984年 | 579篇 |
1983年 | 567篇 |
1982年 | 552篇 |
1981年 | 446篇 |
1980年 | 395篇 |
1979年 | 327篇 |
1978年 | 343篇 |
1977年 | 411篇 |
1975年 | 295篇 |
1972年 | 314篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
Status migrainosus is defined by the international classification of headache disorders (ICHD) criteria as a debilitating migraine lasting more then 72 hours. The epidemiology of status migrainosus is still unknown in adult and children, and frequently underdiagnosed. Children and adolescents often end up in the emergency room with an intractable headache that failed outpatient therapy. Six to seven percent of these children do not respond to acute infusion therapy and require hospitalization. It is imperative that more aggressive therapy is considered when patients are affected by a severe intractable headache to prevent further disability and returning the child to baseline activity. Multiple therapies are available for adults and children. Studies for acute therapy in the emergency room are available in adults and pediatric groups. Small studies are available for inpatient therapy in children and, along with available therapies for children and adolescents, are described in this review. A review of the literature shows growing evidence regarding the use of dihydroergotamine intravenously once patients are hospitalized. Effectiveness and safety have been proven in the last decades in adults and small studies in the pediatric populations. 相似文献
84.
85.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485
86.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
87.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
88.
89.
90.
Philippe A. Eigenmann Motohiro Ebisawa Matthew Greenhawt Jonathan O’B Hourihane Tamara T. Perry Benjamin C. Remington Robert A. Wood 《Pediatric allergy and immunology》2021,32(4):658-666
Risk is a concept inherent in every medical procedure. It can be defined as the probability of an adverse event in a defined population over a specified period of time. In the frame of food allergy management, it might be related to a diagnostic procedure, a treatment, or the consumption of foods. The risk of an adverse event can also be augmented by individual factors. This rostrum article discusses various aspects faced by children with food allergies in the light of risk, and their practical implications. Identifying personal risks for severe reaction, such as unstable asthma, and correcting them whenever possible also contribute to a reduction of the risk inherent to food allergy. Among the facets discussed, oral food challenges (OFC) are the most common diagnostic procedures implying an inherent risk. The risk of OFCs can be minimized by correct indication and timing of the test, a safe setting, as well as by ensuring that the patient is otherwise well without potential stressor potentially increasing the risk of a more severe reaction. Oral immunotherapy (OIT) has been studied as a potential treatment for increasing the threshold dose for reaction, and thus reducing the risk of accidental reaction. Nevertheless, the procedure is not devoid of risk as the patients may and do often react during the course of the procedure. Ingestion of trace amounts in processed foods, mainly in community settings such as restaurants, schools, or day care, represents a potential risk of reactions, although for a minority of patients. Precautionary allergen labeling (PAL) is a widespread strategy to reduce the potential risk of reactions due to traces. However, PAL is currently inefficient due to inconsistent labeling, also not indicating a clear maximum amount possibly present in the manufactured food. Finally, cost-effectiveness needs to be considered in risk management, as many risk reduction procedures are clearly not cost-effective. 相似文献